Investing Profile

Shaan C. Gandhi

InvestorVC

Principal at Longwood Fund

northpondventures.com/team/Boston, Massachusetts

Your Intro Paths to Shaan C. Gandhi

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Networks Shaan C. is a member of

McKinsey & Company Network

274 CONNECTIONS

University of Oxford Network

158 CONNECTIONS

Harvard Medical School Network

20 CONNECTIONS

Harvard Medical School Network

20 CONNECTIONS

Case Western Reserve University Network

18 CONNECTIONS

Find Shaan C. Gandhi on

cb

Current Investing Position

Longwood Fund Principal

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

10

Shaan C. Gandhi is on these Sector & Stage Rankings

BioTech (Series B)Medical Devices (Series B)Medical Devices (Series A)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)Boston / New England Digital Health (Series B)Health IT (Series B)Digital Health (Series A)

Shaan C. Gandhi's Investments On Record (7)

Company	StageDateRound Size	Total Raised
Kyverna Therapeutics	Series BAug 2023$60M Series BJan 2022$85M	$170M
Co-investors: Beth Seidenberg (Kleiner Perkins)
Opna Bio	Series ANov 2022$38M	$38M
CAMP4 Therapeutics	Series BJul 2022$100M Series AJun 2021$45M	$230M
Co-investors: Jorge Conde (Andreessen Horowitz), Andrew Schwab (5am Ventures)
Transition Bio	Series AJun 2022$50M	$50M
Triumvira Immunologics	Series AMar 2022$45M Series AAug 2020$55M	$100M
Co-investors: Widya Mulyasasmita (B Capital Group), Robert Mittendorff (B Capital Group)
Stratus Therapeutics	Series ASep 2021$72M	$180M
Co-investors: Eric Aguiar (Aisling Capital), Carl Gordon (OrbiMed Advisors)
StrideBio	Series BMar 2021$82M	$98M
Co-investors: Karen Hong (Novo Ventures), Jayson Punwani (Abingworth)

Shaan C. Gandhi's Experience

Board Member DiCE MoleculesPresent

Board Member Garuda TherapeuticsPresent

Vice President and Head of Partnerships, PAVE PfizerPresent

Independent Board Member 1910Present

Vice President and Head of Strategic Partnerships, Pfizer Ignite PfizerPresent

Board Member Vigil NeurosciencePresent

Board Member DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and CompanyPresent

Board Member Transition Bio, Inc.Present

Board Member Kyverna TherapeuticsPresent

Board Member Opna BioPresent

Board Member Totus MedicinesPresent

Board Member Incendia TherapeuticsPresent

Board Member Mestag TherapeuticsPresent

Board Member Stratus TherapeuticsPresent

Board Member CAMP4 TherapeuticsPresent

Board Member StrideBio, IncPresent

Board Member TeckroPresent

Board Member Candel TherapeuticsPresent

Director Northpond VenturesPresent

Board Member Aro BiotherapeuticsPresent

Board Member Triumvira Immunologics, Inc.Present

Co-Founder and President Pyxis OncologyPresent

Principal Longwood FundPresent

Assistant in Medicine Massachusetts General HospitalPresent

Instructor Harvard Medical SchoolPresent

Resident Physician in Internal Medicine Massachusetts General HospitalPresent

Clinical Fellow in Medicine Harvard Medical SchoolPresent

Summer Associate McKinsey & CompanyPresent

Shaan C. Gandhi's Education

Case Western Reserve University BS Biochemistry

University of Oxford DPhil Medical Oncology

Investors who invest with Shaan C. Gandhi

Aleks Radovic-Moreno

Annalisa D'Andrea

Christoph Westphal

David Steinberg

Founders who looked at Shaan C. Gandhi's profile also looked at these Scouts & Angels

Bernard Arnault